Cargando…

Can We Accurately Assess Liver Fibrosis with Fibroscan® Using Fewer Valid Measurements?

Detalles Bibliográficos
Autores principales:	Pournik, Omid, Alavian, Seyed Moayed, Eslami, Saeid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2013
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575979/ https://www.ncbi.nlm.nih.gov/pubmed/23364995 http://dx.doi.org/10.3349/ymj.2013.54.2.541

Ejemplares similares

A diagnostic model for cirrhosis in patients with non-alcoholic fatty liver disease: an artificial neural network approach
por: Pournik, Omid, et al.
Publicado: (2014)

Liver Hemangioma Might Lead to overestimation of Liver Fibrosis by Fibroscan; A Missed Issue in Two Cases
por: Aalaei-Andabili, Seyed Hossein, et al.
Publicado: (2012)

Inter-observer and Intra-observer Agreement in Pathological Evaluation of Non-alcoholic Fatty Liver Disease Suspected Liver Biopsies
por: Pournik, Omid, et al.
Publicado: (2014)

Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis
por: Hashemi, Seyed-Abbas, et al.
Publicado: (2016)

Lower Intrafamilial Transmission Rate of Hepatitis B in Patients With Hepatitis D Coinfection: A Data-Mining Approach
por: Pournik, Omid, et al.
Publicado: (2013)

Herbal medicine and liver disease, for any conclusion we need to do more studies
por: Alavian, Seyed Moayed
Publicado: (2011)

Fibroscan for assessing liver fibrosis: An acceptable alternative for liver biopsy: Fibroscan: an acceptable alternative for liver biopsy
por: Malekzadeh, Reza, et al.
Publicado: (2011)

Update of liver fibrosis and steatosis with transient elastography (Fibroscan)
por: Wong, Grace Lai-Hung
Publicado: (2013)

Validation of Novel Fibrosis Index (NFI) for assessment of liver fibrosis: comparison with transient elastography (FibroScan)
por: Hussain, Azhar, et al.
Publicado: (2019)

Quantitative Evaluation of Liver Fibrosis on T1 Relaxometry in Comparison with Fibroscan
Publicado: (2020)

Volatile Anesthetics in Ischemic Liver Injury: Enemy or Friend?
por: Mohseni, Masood, et al.
Publicado: (2014)

Epidemiology of Hepatitis B Virus Infection and the Main Risk Factors in Pakistan Needs More Attention
por: Alavian, Seyed Moayed
Publicado: (2011)

Hepatitis A in Developed Country, the Result Should Interpret Carefully
por: Alavian, Seyed-Moayed
Publicado: (2011)

Hepatitis A virus vaccination in Iranian soldiers needs more attention
por: Alavian, Seyed Moayed
Publicado: (2016)

Occult Hepatitis B in Hemodialysis Patients is a Debate
por: Alavian, Seyed Moayed
Publicado: (2018)

Immigration and knowledge, education, and practices regarding chronic hepatitis B in pregnancy
por: Alavian, Seyed Moayed
Publicado: (2018)

How Can We Make Decision for Patients With Chronic Hepatitis B According to Hepatitis B Virus (HBV) DNA Level?
por: Keshvari, Maryam, et al.
Publicado: (2014)

Acute Fatty Liver of Pregnancy: A Life-Threatening Condition Requiring a Life-Saving Approach
por: Gorginzadeh, Mansoureh, et al.
Publicado: (2016)

Letter to the Editor: Should We Really Take Anti-Viral Therapy into Account in Chronic Hepatitis B Patients with Normal Liver Function?
por: Khosravi, Mohammad Hossein, et al.
Publicado: (2016)

Fibroscan improves the diagnosis sensitivity of liver fibrosis in patients with chronic hepatitis B
por: HUANG, RENGANG, et al.
Publicado: (2016)

Anesthesia for Patients With Liver Disease
por: Rahimzadeh, Poupak, et al.
Publicado: (2014)

Liver Biopsy Versus Non-Invasive Tests in Determining Liver Disease Status
por: Alavian, Seyed Moayed
Publicado: (2015)

Celiac Disease and Abnormal Liver Function Test
por: Nejad, Mohammad Rostami, et al.
Publicado: (2012)

FibroScan Detection of Fatty Liver/Liver Fibrosis in 2266 Cases of Chronic Hepatitis B
por: He, Tingshan, et al.
Publicado: (2020)

Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis
por: Friedrich-Rust, Mireen, et al.
Publicado: (2010)

The Therapeutic Use of Analgesics in Patients With Liver Cirrhosis: A Literature Review and Evidence-Based Recommendations
por: Imani, Farnad, et al.
Publicado: (2014)

More Risk Factors of Hepatitis C Transmission Should be Considered in Pakistan
por: Alavian, Seyed Moayed, et al.
Publicado: (2011)

letter to Hajiani E, Hashemi SJ, Masjedizadeh A, Shayesteh AA, Jalali F. Genotypic Analysis of Hepatitis C Virus in Khuzestan Province, Southwestern Iran. Middle East J Dig Dis 2011;3:126-30
por: Alavian, Seyed Moayed, et al.
Publicado: (2012)

Prospective Validation of ELF Test in Comparison with Fibroscan and FibroTest to Predict Liver Fibrosis in Asian Subjects with Chronic Hepatitis B
por: Kim, Beom Kyung, et al.
Publicado: (2012)

How Many Valid Measurements Are Necessary to Assess Liver Fibrosis Using FibroScan® in Patients with Chronic Viral Hepatitis? An Analysis of Subjects with at Least 10 Valid Measurements
por: Jang, Hui Won, et al.
Publicado: (2012)

The discriminatory ability of FibroScan liver stiffness measurement, controlled attenuation parameter, and FibroScan–aspartate aminotransferase to predict severity of liver disease in children
por: Chaidez, Alexander, et al.
Publicado: (2022)

Fewer permutations, more accurate P-values
por: Knijnenburg, Theo A., et al.
Publicado: (2009)

Use of aspartate aminotransferase to platelet ratio to reduce the need for FibroScan in the evaluation of liver fibrosis
por: Wong, Stephanie, et al.
Publicado: (2017)

YMDD motif mutation after lamivudine therapy
por: Jazayeri, Seyed Mohammad, et al.
Publicado: (2011)

Combination of Fibrosis-4, liver-stiffness measurement, and Fibroscan-AST score to predict liver-related outcomes in nonalcoholic fatty liver disease
por: Wong, Yu Jun, et al.
Publicado: (2023)

IL28B SNP genotyping among Iranian HCV-infected patients: A preliminary report
por: Mahboobi, Nastaran, et al.
Publicado: (2011)

The Key Role of Non-governmental Organizations (NGOs) Activities in Viral Hepatitis Elimination Programs
por: Padami, Farzaneh, et al.
Publicado: (2018)

Prediction of Liver-Related Events Using Fibroscan in Chronic Hepatitis B Patients Showing Advanced Liver Fibrosis
por: Kim, Seung Up, et al.
Publicado: (2012)

Opioid Drugs in Patients With Liver Disease: A Systematic Review
por: Soleimanpour, Hassan, et al.
Publicado: (2016)

Comparative Accuracy of Clinical Fibrosis Markers, Hepascore and Fibroscan® to Detect Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Bertot, Luis C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r18r2u23446irabdhqkg4dmst8